Material
I
nterleukin-15 is a common g chain (CD132) cytokine that functions through a unique mechanism of delivery termed transpresentation. IL-15 has a very high affinity (1.4 3 10 211 M)
for its private receptor, IL-15Ra (1). The two proteins bind within the cell and are shuttled to the surface as a complex (2). IL-15 is then presented in trans to responding cells, such as NK cells, CD8 memory T cells, and intraepithelial lymphocytes (IELs), that express the other two shared chains of the receptor, CD132 and IL-2/ 15Rb (CD122) (3) . The generation of both IL-15 and IL-15Ra knockout (KO) mice has greatly facilitated our ability to study the dramatic downstream effects that exist in the absence of IL-15 signaling (4, 5) . Importantly, transferring NK cells or CD8 T cells from IL-15Ra KO mice to wild-type (WT) recipients demonstrated that IL-15-dependent cells need not express the IL15Ra chain to mediate the downstream effects of IL-15 signaling (6) (7) (8) . For this reason, trans-presentation is largely accepted as the primary mechanism of IL-15 delivery. Whether cis-presentation of IL-15 occurs in vivo is currently unclear but remains feasible (9) . First, CD8 T cells are known to upregulate IL-15Ra expression following activation (10) , and second, impaired development and activation of IL-15-dependent cells is observed in transgenic mice engineered to express a chimeric cytokine receptor composed of the external domain of IL-15Ra fused to the intracellular portion of IL-2Ra, suggesting that cell-intrinsic signaling through IL15Ra is required for the generation of optimal immune responses (11) . Many elegant studies have addressed the cell-cell interactions that drive IL-15-dependent responses, including the cellular sources of IL-15 in vivo (reviewed in Ref. 12) . Early studies used the generation of bone marrow (BM) chimeras to distinguish IL-15 derived from hematopoietic (radio-sensitive) versus nonhematopoietic (radio-resistant) sources (6, 8, 13) . In total, these studies showed that individual populations of IL-15-dependent cells are varied in their requirements for IL-15 from distinct sources. For example, peripheral NK cells and memory CD8 T cells are partially restored when IL-15 production is limited to hematopoietically derived cells whereas IL-15 trans-presentation by radio-resistant intestinal epithelial cells is necessary and sufficient for the generation and maintenance of CD8aa + IELs (14) . Consistent with their association intracellularly, these studies have also shown that the same cell must express both IL-15 and the IL15Ra to mediate activity (15, 16) . Recent approaches have used transgenic expression of IL-15Ra limited to certain subsets of cells and conditional deletion of IL-15Ra using Cre-lox technology to more closely examine the significance of IL-15 from selected in vivo sources (17) (18) (19) (20) (21) . These studies have implicated a role for dendritic cells (DCs) in trans-presenting IL-15 to many subsets of immune cells, yet they also suggest that other cellular sources of IL-15 likely work in conjunction with DCs to maintain overall peripheral homeostasis.
The overt lymphoproliferative disease observed when IL-15 is produced in excess is evidence that IL-15 expression must be tightly regulated (22) . However, IL-15 itself has proven much more difficult to study. This is likely the combined result of overall low levels of IL-15 in the steady-state and possibly poor detection reagents, which in some cases may be further hindered when IL-15 is bound to IL-15Ra. To overcome these hurdles in IL-15 detection, we generated a bacterial artificial chromosome transgenic mouse strain in which emerald GFP (EmGFP) is produced under control of the IL-15 promoter and all upstream regulatory elements (EmGFP/ IL-15). We employed this tool to identify previously unappreciated differences in the respective levels of IL-15 produced by individual subsets of conventional DCs (cDCs) during homeostasis and successfully measure changes in IL-15 expression in DCs following virus infection (23) . In this study, we use EmGFP/IL-15 reporter mice to further identify novel subsets of cells capable of producing IL-15 and examine developmental pathways that regulate IL-15 expression in immune cells, which largely result in limiting IL-15 production to cells of the myeloid lineage.
Materials and Methods
Mice C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and the National Cancer Institute-Charles River (Fredericksburg, MD), and IL-15 2/2 mice were purchased from Taconic (Germantown, NY). EmGFP/IL-15 reporter transgenics were bred and maintained at the University of Connecticut Health Center. All mice were used between 6 and 20 wk of age and housed according to the guidelines at the University of Connecticut Health Center and MD Anderson Cancer Center. All experiments were performed with the approval of the respective Institutional Animal Care and Use Committees.
Tissue isolation
Spleen and thymus were harvested in complete media and crushed through a 70-mm filter. BM was isolated by rapid centrifugation directly into complete media. Peritoneal exudate cells were collected by injecting ∼10 ml PBS into the peritoneal cavity and collecting the solution after 5 min. RBC lysis was performed by incubating single-cell suspensions in Tris ammonium chloride for 5 min at 37˚C.
Flow cytometry and cell sorting
All Abs and Live/Dead viability dye were purchased from BD Biosciences, BioLegend, and eBioscience. Fc block (anti-CD16/32; clone 2.4G2) was purchased from Bio X Cell (West Lebanon, NH). IL-15 was detected with rabbit anti-IL-15 biotin (PeproTech, Rocky Hill, NJ) followed by streptavidin-allophycocyanin (Jackson ImmunoResearch Labratories, West Grove, PA). Background staining was determined by examining analogous populations from IL-15 2/2 mice.
In vitro culture
For IL-15 detection, 10 7 whole splenocytes or BM cells were cultured overnight with or without LPS (1 mg/ml; Sigma-Aldrich, St. Louis, MO) or IFN-a (300 U/ml; PBL Interferon Source and provided by Willem Overwijk [MD Anderson]). For in vitro culture with OP9 stromal cells, experiments were performed as previously described (24 2 ) isolated from the BM were transferred to congenic recipients, and the spleens of recipient mice were harvested after 6 d, as previously described (25) .
Statistics
Statistical analysis was performed using Prism software (GraphPad Software, San Diego, CA) using a Student t test or ANOVA where appropriate.
Results

IL-15 is expressed at the highest levels in myeloid lineages
To facilitate the detection of IL-15 in vivo, our laboratory has recently generated a transgenic bacterial artificial chromosome reporter mouse in which EmGFP is expressed under the control of the promoter and upstream regulatory elements of the IL-15 gene locus (23) . Our analysis of these mice confirmed previously published studies that show IL-15 production by DCs and monocytes (26, 27) . However, the ability to use flow cytometry and EmGFP expression as a surrogate for IL-15 promoter activity has revealed previously unappreciated differences in the relative levels of EmGFP/IL-15 expression in individual subsets of cells, particularly CD8 + and CD8 2 DCs (Ref. 23 and Fig. 1A ), and these results were recently corroborated using a second transgenic IL-15 reporter line (28) . To further identify potentially novel cellular sources of IL-15, we performed a large-scale analysis of both innate and adaptive immune cell subsets in transgenic mice (Tg + ) and transgene-negative (Tg 2 ) littermate controls using the mean fluorescence intensity (MFI) of EmGFP as an indicator of IL-15 transcription (Fig. 1A) . The phenotypic definitions used to identify each population of immune cells by flow cytometry are shown in Supplemental Table I . We found that EmGFP/IL-15 was highly expressed in splenic myeloid cells, including neutrophils, basophils, and eosinophils, and mast cells isolated from the peritoneal cavity ( Fig. 1A, 1B ). Alternatively, we found a lack of EmGFP/IL-15 expression in lymphoid lineages, particularly CD4 + T cells and follicular B cells (Fig. 1C, 1D ). Interestingly, NK and NKT cells along with marginal zone B cells, which are described as more "innate-like" subsets of the immune system, maintained low but detectable levels of EmGFP/IL-15 expression (Fig. 1D, 1E ). However, unlike their cDC counterparts, plasmacytoid DCs (pDCs) expressed EmGFP/IL-15 at very low levels (Fig. 1F ). Thus, we observed an apparent bifurcation regarding IL-15 promoter activity that was largely associated with myeloid versus lymphoid cell fate.
Initial attempts to measure cell-surface IL-15 expression using a flow cytometry-based detection method have been largely unsuccessful. However, two reports have detected IL-15 protein in BMDCs and Gr-1 + polymorphonuclear cells (29, 30) , and using the same reagents we have also detected surface IL-15 on subsets of DCs (17) . Given the success of this particular Ab in detecting trans-presented IL-15, we sought to measure IL-15 protein directly ex vivo on the populations of granulocytes that exhibited high levels of IL-15 transcription based on EmGFP expression. Unfortunately, we were unable to detect IL-15 expression directly ex vivo on any of the cell populations identified in Fig. 1 isolated from the spleen or BM (Supplemental Fig. 1A ). However, we were also unable to detect IL-15 directly ex vivo on CD11c + splenocytes (Supplemental Fig. 1B ). In our previous studies, IL-15 was only detectable when the cells were subjected to an overnight in vitro culture or exposed to TLR ligands (17) . Therefore, we decided to take a similar approach to detect IL-15 protein on granulocytic cells. When we cultured splenocytes overnight in media alone, we detected low levels of IL-15 on neutrophils and eosinophils, using CD11c high DCs and IL-15 2/2 mice as a control for IL-15 staining ( Fig. 2A) . Interestingly, when we performed similar overnight cultures with BM cells, we were also able to detect surface IL-15 on neutrophils, eosinophils, and macrophages ( Fig. 2B ). To further explore the potential of these novel sources of IL-15 to produce protein, we stimulated cells from the spleen and BM with LPS or IFN-a to determine whether these known inducers of IL-15 could augment IL-15 expression in the above populations. Surprisingly, all subsets were able to upregulate IL-15 expression to some degree compared with both unstimulated controls and stimulated IL-15 KO cells (Fig. 2) . Thus, in vitro detection of IL-15 in neutrophils and eosinophils correlated with the findings from our reporter mice indicating that these granulocytic populations have the capacity to produce IL-15 protein.
Hematopoietic progenitors express high levels of IL-15 Fig. 3B, 3C ). Such elevated levels were maintained within the c-Kit + fraction of CD25-expressing DN2 cells as well. The downregulation of EmGFP/IL-15 began as DN2 cells lost c-Kit expression (Fig. 3C) , and EmGFP/IL-15 expression was significantly reduced at the transition between DN2 and DN3 cells (Fig. 3B, 3C ). By the DN4 stage, EmGFP/IL-15 expression was completely lost in committed T cells, and it remained absent from all downstream subsets including double-positive and single-positive cells (Fig. 3B, 3C) . Thus, these data suggested that the signaling pathways controlling the progression of DN2 to DN3 cells could be responsible for initiating the downregulation of IL-15.
Notch signaling mediates IL-15 downregulation during thymopoiesis
The role of Notch in driving T cell development has been well studied (32) , and it is thought that Notch signaling not only initiates the necessary program for T cell development but also turns off any residual expression of myeloid-specific factors (33 The Journal of Immunologyexpressed high levels of EmGFP/IL-15, albeit at significantly reduced levels compared with the LSK cells (Fig. 5A, 5B) + cells was largely sufficient to restore memory CD8 T cells in the periphery but failed to reconstitute the IEL compartment of the intestine (17) . Alternatively, IELs require IL-15 to be delivered by intestinal epithelial cells (18, 21) . Because many of the progenitor and granulocytic populations that we have shown in this study to express IL-15 are present at extremely low frequencies, it will likely be difficult to examine their individual contributions in maintaining IL-15-dependent homeostasis in vivo. Additionally, it is highly likely that some degree of compensatory mechanisms exists when manipulation of IL-15/IL-15Ra expression occurs. For example, when IL-15Ra is conditionally deleted from both CD11c + and LysM + cells, the defect in NK cell homeostasis is not exacerbated above deletion in either subset alone, suggesting that CD11c + cells and LysM + cells provide similar functions in the absence of the other (21) .
The BM has been suggested as a site of long-term memory CD8 and CD4 T cell maintenance (35) (36) (37) (38) , and this is perhaps the result of IL-15 reservoirs present in that site. Snell et al. (39) identified a subset of memory CD8 T cells in the BM that expressed high levels of glucocorticoid-induced TNFR (GITR) but were absent from secondary lymphoid tissues in the periphery and also from the BM of IL-15-deficient mice. They further showed that memory CD8 T cells upregulated GITR in response to IL-15 signaling in vitro and upregulated GITR upon migration into the BM, suggesting that IL-15 signals were delivered specifically within the BM. Similarly, studies in humans have demonstrated the close proximity of CD8 and CD4 memory T cells to IL-15-producing cells in the BM (40) . Whereas others have shown that IL-15 can be expressed by BM stromal cells (26, 41) , to our knowledge ours is the first study describing IL-15 expression by hematopoietic progenitor cells residing in the BM. Interestingly, HSCs have been shown to reside in a specific BM niche using a CXCL12/CXCR4-dependent mechanism (42) , and memory T cell behavior in the BM can also be influenced by CXCL12 (36) . Furthermore, IL-15 signaling can induce CXCR4 expression on in vitro-generated CD4 memory T cells, which perhaps results in the juxtaposition of memory T cells with IL-15-producing hematopoietic progentiors (43) . Regardless, evidence clearly suggests that some IL-15 is derived from hematopoietic sources in the BM, enough to significantly increase the presence of NK cells in the BM of IL-15 KO mice reconstituted with WT BM (14) . Interestingly, however, deletion of IL-15Ra from DCs had no effect on the presence of memory CD8 T cells specifically within the BM (21). This may not be surprising considering the relatively low numbers of DCs present in this location and the expression of IL-15 by a number of other cell types that likely act in conjunction with stromal cells to drive IL-15-dependent responses in the BM.
Our studies show that steady-state IL-15 expression is linked to a myeloid cell fate. There are numerous transcriptional networks at play in the myeloid versus lymphoid cell fate decision, and it is highly unlikely that a single transcription factor will be identified that regulates all instances of IL-15 expression in hematopoietic cells. However, one potential candidate is the ets family member PU.1 (encoded by Sfpi1), which is essential for myeloid cell development, including macrophages and DCs (44) (45) (46) (47) (48) . Also important for B cell development, gradations of PU.1 expression in progenitor cells drive the generation of B lymphocytes versus macrophages (49) . Alternatively, concurrent with commitment to the T cell lineage is a loss of expression of myeloid-specific transcription factors (33, 50) . In fact, constitutive expression of PU.1 is sufficient to block T cell development at the DN to doublepositive transition (51) . However, recent studies have shown that ETPs maintain a significant level of PU.1 expression and retain myeloid potential, whereas DN3 cells, which are committed to T cell development, lack PU.1 expression (33) . We observed a similar pattern of IL-15 expression in developing T cells where IL-15 was expressed at high levels by ETPs, but Notch signaling led to the downregulation of IL-15 in DN3 and DN4 cells, perhaps We further found that IL-15 expression was continuously modulated during myelopoiesis, particularly in the development of DC subsets. The Flt3/Flt3L signaling axis plays a dominant role in controlling DC development (55) . This conclusion has been established in vivo (56, 57) but is also apparent using Flt3L (as opposed to GM-CSF) to generate DCs from BM progenitors in vitro (34) . Considering these two commonly used approaches for generating BMDCs, it is interesting that previous work shows that CD8 + memory T cells are better maintained by Flt3L-derived DCs than those grown in GM-CSF (58) , which could suggest a preferential role for Flt3 signaling in driving optimal IL-15 expression by terminally differentiated DCs. Flt3/Flt3L is also critical for the generation of pDCs, which we have shown lack IL-15 expression. pDCs are unique from their conventional counterparts because they share similarities with developing lympho- cDCs is currently unknown. However, our data, both in vivo and in vitro, indicated that CD8 + DCs express higher levels of IL-15. Id2, IRF8, and Batf3 have all been shown to be required for CD8 + DC development, but whether these specific transcription factors act at the IL-15 locus remains to be examined. The differential expression of IL-15 by cDC subsets has consequences in vivo, as both CD8 + DCs and IL-15Ra were required to maintain a unique population of CD122 + Ag-inexperienced CD8 T cells that exhibit a memory phenotype (28) . Importantly, our previous studies have demonstrated that both subsets of cDCs have the capacity to upregulate IL-15 expression following virus-induced inflammation in an IFN-a receptor-dependent fashion, suggesting that the downregulation of IL-15 by immature CD8
2 DCs does not involve permanent modifications to the gene locus (23) .
In conclusion, the use of an IL-15 reporter transgenic system has facilitated the identification of immune cells with the potential to produce IL-15 in vivo. We have shown a large-scale bifurcation in the two lineages of hematopoietically derived cells whereby IL-15 expression is primarily limited to myeloid cells and downmodulated during lymphoid cell development. Surprisingly, IL-15 was expressed at high levels by HSCs in the BM, and IL-15 regulation occurred during both thymopoiesis and DC development. In total, our findings suggested that molecular mechanisms responsible for the development of cells in both myeloid and lymphoid lineages were also able to exert regulatory control at the IL-15 gene locus.
